IHRD-46
Response
Accepted
Clinician Attendance at Post-Mortem Discussions
Recommendation
Where possible, treating clinicians should attend for clinico-pathological discussions at the time of post-mortem examination and thereafter upon request.
Published Evidence Summary
The following publicly available evidence relates to this recommendation:
- HSC Trusts reported that mortality review processes for child deaths had been formalised (IHRD Implementation Programme, Department of Health NI, March 2018).
- No independent published verification of implementation has been identified.
- No independent published verification of implementation has been identified.
How was this evidence gathered?
Evidence searched by Claude (Anthropic) on 17 Jul 2026
Checked data held on this site (government responses, progress updates, independent evidence)
This recommendation applies across many organisations. The evidence above reflects central policy activity; adoption in individual organisations may vary.
Jurisdiction
Northern Ireland
Response
Accepted
Response
Accepted
Accepted
HSC Trusts
01 Mar 2018
Guidance issued on clinician attendance at clinico-pathological discussions.
Source
Inquiry
Hyponatraemia Inquiry
Report
Report of the Inquiry into Hyponatraemia-related Deaths
31 Jan 2018
Responsible Bodies
HSC Trusts
Primary
Themes & Tags
Recommendation age
8.5 yrs
Last formal update
910 days ago